Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Total 13F shares
-
5,323,228
-
Share change
-
+30,239
-
Total reported value
-
$10,112,228
-
Put/Call ratio
-
3.8%
-
Price per share
-
$1.90
-
Number of holders
-
17
-
Value change
-
+$57,455
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q3 2024
As of 30 Sep 2024,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,323,228 shares.
The largest 10 holders included
Knoll Capital Management, LLC, Schonfeld Strategic Advisors LLC, Parkman Healthcare Partners LLC, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, SIGNATURE ESTATE & INVESTMENT ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and OSAIC HOLDINGS, INC..
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.